Oxaliplatin and neuropathy: A role for sodium channels

Ensuring long-term quality of life in cancer survivors following treatment is critically important, particularly given the increasing effectiveness of treatments. Chemotherapy-induced peripheral neuropathy (CIPN) remains a major side effect of cancer therapy, with many commonly used chemotherapies, leading to early cessation and long-lasting disability (Park et al., 2013).

http://ift.tt/2zIPiE7